These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17047104)

  • 1. An unfavourable prognosis for pancreatic cancer indicates fields of opportunity.
    Greenhalf W
    Gut; 2006 Nov; 55(11):1533-5. PubMed ID: 17047104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-ras as a genetic marker in pancreatic cancer.
    Nakayama T; Morishita T; Kamiya T
    Acta Gastroenterol Latinoam; 2003; 33(1):43-6. PubMed ID: 14708511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of the Ki-ras mutation as a specific and sensitive marker of pancreatic carcinoma].
    Krechler T; Janda J; Dufek V; Kaláb M; Pesková M; Dorazilová V
    Vnitr Lek; 1997 Oct; 43(10):678-81. PubMed ID: 9601883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of micrometastases after curative resection for ductal adenocarcinoma of the pancreas].
    Niedergethmann M; Rexin M; Knob S; Hartel M; Sturm JW; Richter A; Post S
    Zentralbl Chir; 2001 Nov; 126(11):917-21. PubMed ID: 11753804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of small pancreatic cancer diagnosed by serial follow-up studies promptly by a positive K-ras point mutation in pure pancreatic juice.
    Ochi K; Hasuoka H; Mizushima T; Matsumura N; Harada H
    Am J Gastroenterol; 1998 Aug; 93(8):1366-8. PubMed ID: 9707068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pancreatic adenocarcinoma with novel K-ras mutation and long term survival.
    Toyooka S; Tsukuda K; Mizuta M; Soh J; Shirakawa K; Shimizu K; Shimizu N
    Am J Gastroenterol; 2002 Jul; 97(7):1852-3. PubMed ID: 12135058
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma.
    Motojima K; Urano T; Nagata Y; Shiku H; Tsunoda T; Kanematsu T
    Am J Gastroenterol; 1991 Dec; 86(12):1784-8. PubMed ID: 1962623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer.
    Lee JG; Urayama S
    Gastrointest Endosc; 2000 Jul; 52(1):138-40. PubMed ID: 11012299
    [No Abstract]   [Full Text] [Related]  

  • 9. K-ras mutation in focal proliferative lesions of human pancreas.
    Terhune PG; Phifer DM; Tosteson TD; Longnecker DS
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):515-21. PubMed ID: 9641496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer.
    Pellegata NS; Losekoot M; Fodde R; Pugliese V; Saccomanno S; Renault B; Bernini LF; Ranzani GN
    Anticancer Res; 1992; 12(5):1731-5. PubMed ID: 1444240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ras-oncogene mutation and pancreatic adenocarcinoma.
    Das A; Aggarwal R
    Indian J Gastroenterol; 1992 Apr; 11(2):101-2. PubMed ID: 1428027
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
    Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of K-RAS and cytokeratine 20 markers in diagnosis of lymphogenic metastasis of pancreatic cancer].
    Zemskov SV
    Klin Khir; 2005 Aug; (8):32-5. PubMed ID: 16445057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
    Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic changes in cancer of the exocrine pancreas].
    Real FX
    Gastroenterol Hepatol; 1996 Dec; 19(10):534-41. PubMed ID: 9044757
    [No Abstract]   [Full Text] [Related]  

  • 18. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
    Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
    Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
    Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
    Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.
    Tada M; Omata M; Kawai S; Saisho H; Ohto M; Saiki RK; Sninsky JJ
    Cancer Res; 1993 Jun; 53(11):2472-4. PubMed ID: 8495407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.